New Hope for Heart Failure Patients: CARDINAL-HF Trial Shows Promising Results
In a groundbreaking study, researchers have investigated the potential of CRD-740, a PDE9 inhibitor, as a treatment for chronic heart failure. The Phase 2, randomized,
In a groundbreaking study, researchers have investigated the potential of CRD-740, a PDE9 inhibitor, as a treatment for chronic heart failure. The Phase 2, randomized,
The PARACOR-19 randomized controlled trial (RCT) has investigated the effects of sacubitril/ valsartan on markers of cardiac injury, inflammation, structure, and function in patients who
A recent study from the Spanish Society of Cardiology-Excellence Heart Failure registry has shed light on the substantial impact of advanced chronic kidney disease (CKD)
Inflammation has been recognized as a crucial factor in the development and progression of heart failure (HF). A recent single-center study involving 4,043 patients discharged
In a recent retrospective analysis of the IRONMAN trial, researchers have found that the efficacy of intravenous (IV) ferric derisomaltose (FDI) is similar in both
This paper was presented on the final day of the 2022 Scientific Sessions of the Society for Cardiovascular Angiography and Interventions (SCAI) held at Atlanta
This paper was presented on the final day of the 2022 Scientific Sessions of the Society for Cardiovascular Angiography and Interventions (SCAI) held at Atlanta
This paper was presented on the final day of the 2022 Scientific Sessions of the Society for Cardiovascular Angiography and Interventions (SCAI) held at Atlanta
This paper was presented on the final day of the 2022 Scientific Sessions of the Society for Cardiovascular Angiography and Interventions (SCAI) held at Atlanta
Transcatheter aortic valve replacement (TAVR) has revolutionized the treatment of aortic stenosis and is now the main treatment of choice for patients older than 80